Estrogen receptor alpha; Estrogen receptor beta (ERα; ERβ)

Estrogen receptor alpha and estrogen receptor beta are closely related nuclear proteins that function as ligand-activated transcription factors, responding primarily to estrogenic hormones such as estradiol. They are encoded by distinct genes—ESR1 for ERα and ESR2 for ERβ—and are expressed in numerous tissues, often at variable levels. Upon ligand binding, these receptors dimerize (forming αα, ββ, or αβ structures), translocate to the nucleus, and regulate the transcription of estrogen-responsive target genes. Their subtype-specific expression and co-activation or repression with different co-regulatory proteins lead to unique roles in tissue development, homeostasis, and disease. ERα is highly expressed in breast, uterus, liver, and bone, while ERβ is prominent in prostate, ovary, colon, and immune tissues. Both are critically involved in signal transduction, cell proliferation, and disease processes, particularly hormone-dependent cancers, making them important diagnostic, prognostic, and therapeutic targets. Receptor modulators and antagonists form the basis for therapies such as SERMs and SERDs in cancer and other estrogen-associated disorders, although there exist notable safety concerns due to systemic estrogenic effects.

Other names

Estrogen receptor 1 (for ERα)ESR1Estrogen receptor 2 (for ERβ)ESR2NR3A1 (for ERα)NR3A2 (for ERβ)ER-alphaER-betaEstrogen receptor alpha/beta

Agonist (activates receptor leading to gene transcription), Antagonist (blocks receptor activity, inhibiting gene transcription), Selective estrogen receptor modulator (SERM; tissue-selective agonist/antagonist effects), Selective estrogen receptor degrader (SERD; promotes receptor degradation)